Improvements in Itch-Related Quality of Life With Difelikefalin for Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies in Hemodialysis Patients

• Molly L. Cahill, APRN, BC, NP-C, CNN, Nurse Practitioner, KC Kidney Consultants
• Steven Fishbane, MD, Chief, Division of Nephrology, Northwell Health
• Thomas Wooldridge, MD
• Warren Wen, PhD
• Catherine Munera, PhD
• Frederique Menzaghi, PhD